HER2 Support Group Forums - View Single Post - Top-line data from Provectus' PH-10 Phase 2 trial on plaque psoriasis

News · 03-19-2012, 04:32 AM

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced top-line data for the company's randomized controlled trial (RCT) of PH-10 for mild-to-moderate plaque psoriasis.

More...

03-19-2012, 04:32 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,983	Top-line data from Provectus' PH-10 Phase 2 trial on plaque psoriasis Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced top-line data for the company's randomized controlled trial (RCT) of PH-10 for mild-to-moderate plaque psoriasis. More...